Cresco Labs FY2025 EPS Estimate Lifted by Atb Cap Markets

Cresco Labs Inc. (OTCMKTS:CRLBF) – Equities research analysts at Atb Cap Markets boosted their FY2025 earnings per share (EPS) estimates for shares of Cresco Labs in a research note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of ($0.07) per share for the year, up from their previous forecast of ($0.09). Atb Cap Markets has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.

Other equities research analysts have also recently issued research reports about the company. Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a report on Monday, November 11th. Roth Capital raised shares of Cresco Labs to a “strong-buy” rating in a research report on Sunday, November 10th. Four investment analysts have rated the stock with a hold rating, two have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Cresco Labs presently has an average rating of “Moderate Buy” and an average price target of $2.50.

Cresco Labs Stock Performance

CRLBF stock opened at $1.00 on Wednesday. The company has a 50-day simple moving average of $1.38 and a 200 day simple moving average of $1.57. The company has a market capitalization of $488.14 million, a P/E ratio of -5.00 and a beta of 1.73. Cresco Labs has a fifty-two week low of $1.00 and a fifty-two week high of $2.65. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.